Wasatch Advisors Inc Cytokinetics Inc Transaction History

Wasatch Advisors Inc

$20.1 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $2.19 Million - $3.12 Million	-61,090 Reduced 14.23%	368,183 $16.9 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $1.78 Million - $2.52 Million	-46,252 Reduced 9.73%	429,273 $20.8 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $23.3 Million - $33.5 Million	-685,320 Reduced 59.04%	475,525 $18.7 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $30.4 Million - $47 Million	-1,022,405 Reduced 46.83%	1,160,845 $42.7 Million
Q4 2021 Feb 15, 2022	SELL	$34.35 - $46.38 $16 Million - $21.6 Million	-464,787 Reduced 17.55%	2,183,250 $99.5 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $996,061 - $1.92 Million	53,725 Added 2.07%	2,648,037 $94.6 Million
Q2 2021 Aug 12, 2021	SELL	$19.79 - $26.99 $305,537 - $416,698	-15,439 Reduced 0.59%	2,594,312 $51.3 Million
Q1 2021 May 10, 2021	BUY	$18.57 - $25.68 $1 Million - $1.39 Million	54,011 Added 2.11%	2,609,751 $60.7 Million
Q4 2020 Feb 12, 2021	SELL	$15.26 - $28.61 $7.46 Million - $14 Million	-488,730 Reduced 16.05%	2,555,740 $53.1 Million
Q3 2020 Nov 10, 2020	BUY	$20.58 - $28.96 $3.74 Million - $5.26 Million	181,579 Added 6.34%	3,044,470 $65.9 Million
Q2 2020 Aug 12, 2020	SELL	$11.15 - $24.64 $1.53 Million - $3.38 Million	-137,022 Reduced 4.57%	2,862,891 $67.5 Million
Q1 2020 May 08, 2020	BUY	$8.75 - $16.3 $3.56 Million - $6.63 Million	406,453 Added 15.67%	2,999,913 $35.4 Million
Q4 2019 Feb 13, 2020	BUY	$7.95 - $11.84 $1.05 Million - $1.56 Million	131,934 Added 5.36%	2,593,460 $27.5 Million
Q3 2019 Nov 14, 2019	SELL	$10.82 - $14.25 $8.17 Million - $10.8 Million	-755,346 Reduced 23.48%	2,461,526 $28 Million
Q2 2019 Aug 07, 2019	BUY	$7.95 - $11.25 $225,660 - $319,331	28,385 Added 0.89%	3,216,872 $0
Q1 2019 May 08, 2019	BUY	$5.95 - $10.19 $4.35 Million - $7.46 Million	731,682 Added 29.78%	3,188,487 $0
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $3.33 Million - $5.24 Million	564,213 Added 29.81%	2,456,805 $15.5 Million
Q3 2018 Nov 07, 2018	BUY	$6.4 - $9.85 $400,275 - $616,048	62,543 Added 3.42%	1,892,592 $0
Q2 2018 Aug 02, 2018	BUY	$6.9 - $9.9 $470,352 - $674,853	68,167 Added 3.87%	1,830,049 $0
Q1 2018 May 02, 2018	BUY	$7.2 - $10.05 $591,148 - $825,145	82,104 Added 4.89%	1,761,882 $0
Q4 2017 Jan 16, 2018	BUY	$7.25 - $15.65 $7.08 Million - $15.3 Million	977,106 Added 139.06%	1,679,778 $0
Q3 2017 Nov 08, 2017	SELL	$12.0 - $15.0 $798,216 - $997,770	-66,518 Reduced 8.65%	702,672 $0
Q2 2017 Aug 16, 2017	BUY	N/A	769,190	769,190 $0

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$766 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$614 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$506 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$406 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$337 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account